美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SPDR S&P Biotech ETF

160.27

-0.5450-0.34%

成交量：143.31萬

成交額：2.31億

市值：109.14億

市盈率：8.79

高：162.51

開：162.04

低：160.20

收：160.81

52周最高：162.51

52周最低：83.45

股本：6,810.00萬

流通股本：6,810.00萬

量比：2.64

換手率：2.10%

股息：0.58

股息率：0.36%

每股收益(TTM):18.23

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

唐山市2026年度職工基本醫療保險最低繳費基數調整

瞭望丨青島：打造海洋生物醫藥高地

Evercore任命Eric Rabinowitz為醫療健康投資銀行部高級董事總經理

环球市场播报

《股市簡訊》香港華夏恒生生科ETF漲5.7%創近兩個月新高，管理人料低估修復

生物科技板塊全面走強生物科技ETF易方達漲2.91%，康龍化成、泰格醫藥升逾5%領升CXO賽道

張琅：健康中國政策的落地進一步釋放商業健康保險空間

醫療保健板塊市場動態綜述

雲康雲科醫療健康科技（廣州）有限公司成立

醫療保健板塊動態：市場熱議聚焦

醫療保健板塊圓桌：市場熱議焦點

景澤生物醫藥（合肥）股份有限公司遞表港交所

邵利鐸：推動健康險三重轉型加快保險與健康管理融合創新

趙長鵬的百億美金投向哪？YZi Labs 投資版圖全曝光

金龍魚旗下富裕生物科技公司增資至25.6億增幅約33%

醫療保健板塊動態：市場熱議焦點

【今日主題前瞻】今年以來全球AI生物醫藥賽道迎來密集合作落地

美國勞工統計局：專業和商業服務、社會援助以及醫療保健領域的就業崗位持續增加。休閒和酒店業的就業崗位減少。

價格成本和認證中心赴北京民海生物科技有限公司調研

昂利康等在杭州成立生物醫藥公司

百誠醫藥等成立生物科技新公司

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/XBI/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":160.265,"timestamp":1783432350667,"preClose":160.81,"halted":0,"volume":1433124,"delay":0,"changeRate":-0.003389092718114644,"floatShares":68100000,"shares":68100000,"eps":18.23,"marketStatus":"交易中","change":-0.545,"latestTime":"07-07 09:52:31 EDT","open":162.04,"high":162.51,"low":160.2,"amount":231043808.5956,"amplitude":0.014365,"askPrice":160.31,"askSize":200,"bidPrice":160.22,"bidSize":4,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1783454400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":160.81,"sharesOutstanding":63325000,"nav":160.522543,"aum":10847310853.205,"dividendRate":0.003612,"bidAskSpread":0.000286,"preHourTrading":{"tag":"盘前","latestPrice":161.95,"preClose":160.81,"latestTime":"09:29 EDT","volume":48593,"amount":7871774.442,"timestamp":1783430999999,"change":1.14,"changeRate":0.007089,"amplitude":0.011307},"postHourTrading":{"tag":"盘后","latestPrice":161.1799,"preClose":160.81,"latestTime":"19:59 EDT","volume":1011885,"amount":163022745.2891,"timestamp":1783382373861,"change":0.3699,"changeRate":0.0023,"amplitude":0.006716},"volumeRatio":2.642032,"impliedVol":0.3492,"impliedVolPercentile":0.9004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":68100000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.642032,"shares":68100000,"dividePrice":0.5789,"high":162.51,"amplitude":0.014365,"preClose":160.81,"low":160.2,"week52Low":83.45,"pbRate":"--","week52High":162.51,"institutionHeld":0.8511,"latestPrice":160.265,"committee":-0.960784,"eps":18.23,"divideRate":0.003612,"volume":1433124,"delay":0,"ttmEps":18.23,"open":162.04,"prevYearClose":121.93,"prevWeekClose":160.46,"prevMonthClose":158.25,"prevQuarterClose":158.25,"fiveDayClose":158.31,"twentyDayClose":128.67,"sixtyDayClose":131.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649803869","title":"唐山市2026年度職工基本醫療保險最低繳費基數調整","url":"https://stock-news.laohu8.com/highlight/detail?id=2649803869","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649803869?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 20:22","pubTimestamp":1783426920,"startTime":"0","endTime":"0","summary":"自2026年7月1日至2027年6月30日，按照2025年全市全口径城镇单位就业人员月平均工资核定个人缴费基数，低于全市全口径城镇单位就业人员月平均工资的，以全市全口径城镇单位就业人员月平均工资为缴费基数，高于全市全口径城镇单位就业人员月平均工资的，以实际工资为缴费基数。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-07-07/doc-inifyvaw8404769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","XLV","LABU","XBI","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649879677","title":"瞭望丨青島：打造海洋生物醫藥高地","url":"https://stock-news.laohu8.com/highlight/detail?id=2649879677","media":"观海新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649879677?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 07:29","pubTimestamp":1783380540,"startTime":"0","endTime":"0","summary":"针对产业发展痛点，青岛近年密集出台支持政策，对海洋创新药最高给予3000万元配套奖补。市属国企青岛国信集团牵头设立主投生命健康和海洋的产业基金，并收购相关制药企业，与中国海洋大学青岛海洋生物医药研究院深度合作形成海洋药物创新共同体。成立于2013年的青岛海洋生物医药研究院，专注海洋一类创新药研发。这种不断向产业链高端攀升的发展逻辑，体现在青岛众多海洋生物医药企业身上。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-07-07/doc-inifxtrh8298791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161726","XBI","BK4588","BK4585","399441","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649362102","title":"Evercore任命Eric Rabinowitz為醫療健康投資銀行部高級董事總經理","url":"https://stock-news.laohu8.com/highlight/detail?id=2649362102","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649362102?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 20:50","pubTimestamp":1783342200,"startTime":"0","endTime":"0","summary":"独立投资银行Evercore今日宣布，Eric Rabinowitz已加入公司，担任医疗健康投资银行部高级董事总经理。　　Rabinowitz在医疗健康投行领域拥有超过二十年的从业经验。加入Evercore前，他在高盛担任医疗健康投行部董事总经理，主导了多项大型生物制药并购和许可交易，交易总价值超过1000亿美元。　　Evercore医疗健康投行部全球负责人表示，Rabinowitz的加入将显著增强团队在生物制药领域的服务能力。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-06/doc-inifwscu8547306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","GABF","XBI","PFI","XLV","BK4581","EVR","KCE","IXJ","LABU","159760","BK4585","VHT","BK4550","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649646268","title":"《股市簡訊》香港華夏恒生生科ETF漲5.7%創近兩個月新高，管理人料低估修復","url":"https://stock-news.laohu8.com/highlight/detail?id=2649646268","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649646268?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 14:51","pubTimestamp":1783320665,"startTime":"0","endTime":"0","summary":"《股市简讯》香港华夏恒生生科ETF涨5.7%创近两个月新高，管理人料低估修复* 追踪恒生生物科技指数.HSBIO的华夏恒生生科3069.HK周一盘中一度涨5.7%至14.78港元，创近两个月新高。他并称，美国同类型ETF-道富健康照护精选产业XLV.P、安硕生物科技IBB.O已创出历史新高，因此判断中国生物科技产业会出现低估修复。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nL4T4380D1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","03069","BK4588","BK4585","XLV","IBB","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649920610","title":"生物科技板塊全面走強 生物科技ETF易方達漲2.91%，康龍化成、泰格醫藥升逾5%領升CXO賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2649920610","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649920610?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 11:07","pubTimestamp":1783307249,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AGNG","MEDX","XBI","GDOC","FDN","BK4550","BK4585","ARTY","CXO","SYNB","XLK","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648998976","title":"張琅：健康中國政策的落地進一步釋放商業健康保險空間","url":"https://stock-news.laohu8.com/highlight/detail?id=2648998976","media":"金融一线","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648998976?lang=zh_tw&edition=fundamental","pubTime":"2026-07-04 17:50","pubTimestamp":1783158600,"startTime":"0","endTime":"0","summary":"　　谈及未来行业发展机遇，张琅表示，健康中国政策的落地进一步释放商业健康保险空间。　　张琅进一步表示，对于健康险，无论是从健康中国还是投资于人，金融监管总局推动健康保险高质量发展、医保局创新药的放开，都是我们的机会。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jryx/insurance/2026-07-04/doc-inifrtka9359402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","XLV","LABU","BK4585","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114431356","title":"醫療保健板塊市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1114431356","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114431356?lang=zh_tw&edition=fundamental","pubTime":"2026-07-04 16:21","pubTimestamp":1783153298,"startTime":"0","endTime":"0","summary":"最新医疗保健板块市场动态。益普生股价下跌1.1%。联昌国际证券分析师表示，受4月和5月意外收益的推动，马来西亚手套制造商的股价预计在8月财报季期间将保持相对坚挺。然而，他预计下半年前景将更具挑战性，因为平均销售价格将随着原材料成本下降和持续的行业产能过剩而下滑。随着固定成本居高不下，利润率压力可能会加剧。联昌国际维持对马来西亚手套制造业的中性评级，并将高产柅品工业列为其首选。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","LABU","XLV","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648695750","title":"雲康雲科醫療健康科技（廣州）有限公司成立","url":"https://stock-news.laohu8.com/highlight/detail?id=2648695750","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648695750?lang=zh_tw&edition=fundamental","pubTime":"2026-07-04 11:33","pubTimestamp":1783135980,"startTime":"0","endTime":"0","summary":"天眼查App显示，近日，云康云科医疗健康科技（广州）有限公司成立，注册资本800万元，经营范围包括健康咨询服务、远程健康管理服务、医学研究和试验发展、人工智能通用应用系统等，由云康健康产业投资股份有限公司全资持股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607043794165922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159760","XLV","BK4581","BK4588","BK4585","BK4550","IXJ","XBI","VHT","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190197931","title":"醫療保健板塊動態：市場熱議聚焦","url":"https://stock-news.laohu8.com/highlight/detail?id=1190197931","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190197931?lang=zh_tw&edition=fundamental","pubTime":"2026-07-04 04:52","pubTimestamp":1783111925,"startTime":"0","endTime":"0","summary":"0848 ET - 益普生集团本周宣布了两项收购，但其首席商务官菲利普·洛佩斯-费尔南德斯在接受采访时表示，这更像是机缘巧合而非预先计划。这家法国制药商表示，将以高达17.5亿美元的价格收购致力于研发罕见血癌药物的Kartos Therapeutics公司，并在另一项可能超过7亿欧元的交易中，收购专注于肾脏感染治疗的Memo Therapeutics公司。联昌国际集团、国家能源公司、IHH医疗保健集团和金务大公司是其首选股票之一。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","XLV","BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138259959","title":"醫療保健板塊圓桌：市場熱議焦點","url":"https://stock-news.laohu8.com/highlight/detail?id=1138259959","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138259959?lang=zh_tw&edition=fundamental","pubTime":"2026-07-04 00:25","pubTimestamp":1783095922,"startTime":"0","endTime":"0","summary":"医疗保健领域的最新市场对话正在热烈进行。0848 ET - 益普生集团本周宣布了两项收购，但该公司首席商务官菲利普·洛佩斯-费尔南德斯在访谈中表示，这更像是机缘巧合而非精心策划的结果。该股股价下跌1.1%。鉴于对成本压力升级可能削弱消费者和企业信心并导致资产质量恶化的担忧，他们对银行盈利采取了更为保守的立场。联昌国际集团、国家能源、综合保健控股和金务大是他们的首选标的之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XLV","BK4585","BK4588","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648664627","title":"景澤生物醫藥（合肥）股份有限公司遞表港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2648664627","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648664627?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 22:56","pubTimestamp":1783090560,"startTime":"0","endTime":"0","summary":"据港交所文件，景泽生物医药（合肥）股份有限公司向港交所提交上市申请书，联席保荐人为中金公司、国元国际。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-07-03/doc-inifpyys3567142.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-07-03/doc-inifpyys3567142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","IPOS","BK4585","BK4581","161726","BK4588","HEXmain","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648683776","title":"邵利鐸：推動健康險三重轉型 加快保險與健康管理融合創新","url":"https://stock-news.laohu8.com/highlight/detail?id=2648683776","media":"金融一线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648683776?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 18:04","pubTimestamp":1783073040,"startTime":"0","endTime":"0","summary":"　　邵利铎表示，立足国家战略部署，医保改革大势，产业升级机遇和民生迭代需求，商业健康保险要主动适应推动发展逻辑变革，从单纯的被动赔付向主动干预，从单一保障向全周期管理，从费用支付向健康服务转型，加快保险与健康管理融合创新，对“十五五”高质量发展培育新动能，夯实新根基。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jryx/insurance/2026-07-03/doc-inifpqkw3594965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4585","BK4581","LABU","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648650147","title":"趙長鵬的百億美金投向哪？YZi Labs 投資版圖全曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2648650147","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648650147?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 17:30","pubTimestamp":1783071059,"startTime":"0","endTime":"0","summary":" 赵长鹏百亿美元新型“家办” YZi Labs 投资版图曝光：七成资金坚守加密生态，三成跨界押注 AI 与生物科技，开启后币安时代的资本新实验 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2274819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HBImain","ROBO","XBI","AGIX","CHAT","ARTY","BK4585","AIPO","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648865452","title":"金龍魚旗下富裕生物科技公司增資至25.6億 增幅約33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648865452","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648865452?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 16:25","pubTimestamp":1783067121,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197470971","title":"醫療保健板塊動態：市場熱議焦點","url":"https://stock-news.laohu8.com/highlight/detail?id=1197470971","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197470971?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 16:25","pubTimestamp":1783067101,"startTime":"0","endTime":"0","summary":"花旗认为，积极的试验结果标志着该药物向获批迈出了重要的第一步，其潜力有望成为又一重磅产品。而花旗估计，仅首项试验就可能释放14亿法郎的峰值销售额，另外两项研究则为进一步提升潜力提供了空间。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","XLV","BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648639713","title":"【今日主題前瞻】今年以來全球AI生物醫藥賽道迎來密集合作落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2648639713","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648639713?lang=zh_tw&edition=fundamental","pubTime":"2026-07-03 07:24","pubTimestamp":1783034656,"startTime":"0","endTime":"0","summary":"　　英硅智能宣布，已与武田制药达成全球战略合作协议，双方将依托英硅智能自主研发的一体化端到端Pharma.AI平台，在武田制药选定多个疾病治疗领域共同推进候选药物研发。根据协议，英硅智能将主导AI驱动的药物发现工作，负责设计并筛选出符合预设科学标准及早期开发标准的候选分子；武田制药则将发挥其强大的全球开发能力，推进相关候选药物的临床验证。　　自今年以来，全球AI生物医药赛道迎来密集合作落地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangceping/20260703/32297787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["AIPO","BK4585","ARTY","XBI","399441","161726","BK4588","AGIX","BK4581","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648507245","title":"美國勞工統計局：專業和商業服務、社會援助以及醫療保健領域的就業崗位持續增加。休閒和酒店業的就業崗位減少。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648507245","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648507245?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 20:32","pubTimestamp":1782995569,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4581","BK4550","VHT","XBI","LABU","XLV","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648550284","title":"價格成本和認證中心赴北京民海生物科技有限公司調研","url":"https://stock-news.laohu8.com/highlight/detail?id=2648550284","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648550284?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 19:42","pubTimestamp":1782992539,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4581","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648570740","title":"昂利康等在杭州成立生物醫藥公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2648570740","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648570740?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 16:28","pubTimestamp":1782980899,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4585","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648344577","title":"百誠醫藥等成立生物科技新公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2648344577","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648344577?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 15:32","pubTimestamp":1782977535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4585","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}